Ventyx Biosciences Inc Sustainability Reports
Ventyx Biosciences, Inc. is a clinical-stage biotechnology company that discovers and develops small-molecule drug candidates for inflammatory diseases and autoimmune disorders. The company's pipeline includes oral therapies targeting NLRP3, TYK2, and S1P1R.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00VC84K47
4 reports from 2021 to 2024